Bar Harbor Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Sell
25,120
-12,824
-34% -$736K 0.08% 134
2026
Q1
$2.3M Sell
37,944
-68
-0.2% -$3.96K 0.13% 117
2025
Q4
$2.05M Sell
38,012
-178
-0.5% -$8.56K 0.12% 128
2025
Q3
$1.72M Buy
38,190
+549
+1% +$25.6K 0.1% 131
2025
Q2
$1.74M Sell
37,641
-135
-0.4% -$6.63K 0.11% 129
2025
Q1
$2.3M Sell
37,776
-1,013
-3% -$59K 0.15% 116
2024
Q4
$2.19M Sell
38,789
-1,060
-3% -$59.2K 0.14% 117
2024
Q3
$2.06M Sell
39,849
-613
-2% -$28.8K 0.13% 128
2024
Q2
$1.68M Sell
40,462
-1,901
-4% -$85.1K 0.11% 131
2024
Q1
$2.3M Buy
42,363
+7,592
+22% +$387K 0.15% 126
2023
Q4
$1.78M Sell
34,771
-1,044
-3% -$54.8K 0.13% 125
2023
Q3
$2.08M Sell
35,815
-1,304
-4% -$79.9K 0.17% 115
2023
Q2
$2.37M Sell
37,119
-1,697
-4% -$114K 0.18% 112
2023
Q1
$2.69M Sell
38,816
-22
-0.1% -$1.55K 0.21% 100
2022
Q4
$2.79M Buy
38,838
+407
+1% +$30.7K 0.22% 94
2022
Q3
$2.73M Sell
38,431
-1,051
-3% -$76.2K 0.24% 92
2022
Q2
$3.04M Buy
39,482
+9,620
+32% +$733K 0.24% 95
2022
Q1
$2.18M Sell
29,862
-2,061
-6% -$138K 0.2% 90
2021
Q4
$1.99M Sell
31,923
-525
-2% -$30.8K 0.17% 97
2021
Q3
$1.92M Sell
32,448
-15
-0% -$988 0.18% 96
2021
Q2
$2.17M Sell
32,463
-620
-2% -$40.4K 0.2% 90
2021
Q1
$2.09M Sell
33,083
-460
-1% -$28.6K 0.2% 90
2020
Q4
$2.08M Hold
33,543
0.21% 89
2020
Q3
$2.02M Sell
33,543
-327
-1% -$19.7K 0.22% 85
2020
Q2
$1.99M Sell
33,870
-1,872
-5% -$112K 0.23% 83
2020
Q1
$1.99M Sell
35,742
-5,206
-13% -$318K 0.27% 81
2019
Q4
$2.63M Buy
40,948
+3,407
+9% +$195K 0.29% 74
2019
Q3
$1.9M Sell
37,541
-875
-2% -$41.1K 0.22% 95
2019
Q2
$1.74M Buy
38,416
+938
+3% +$43.7K 0.2% 103
2019
Q1
$1.79M Sell
37,478
-698
-2% -$34.8K 0.21% 95
2018
Q4
$1.98M Sell
38,176
-1,101
-3% -$59.2K 0.26% 84
2018
Q3
$2.44M Sell
39,277
-141
-0.4% -$8.37K 0.28% 83
2018
Q2
$2.18M Sell
39,418
-2,242
-5% -$121K 0.26% 86
2018
Q1
$2.63M Buy
41,660
+3,249
+8% +$209K 0.32% 74
2017
Q4
$2.35M Buy
38,411
+1,690
+5% +$106K 0.27% 78
2017
Q3
$2.34M Sell
36,721
-2,715
-7% -$159K 0.28% 75
2017
Q2
$2.2M Sell
39,436
-2,151
-5% -$117K 0.26% 77
2017
Q1
$2.26M Sell
41,587
-7,307
-15% -$401K 0.26% 73
2016
Q4
$2.86M Buy
48,894
+868
+2% +$47.5K 0.32% 71
2016
Q3
$2.59M Buy
48,026
+357
+0.7% +$22.9K 0.29% 76
2016
Q2
$3.51M Buy
47,669
+718
+2% +$50.7K 0.41% 57
2016
Q1
$3M Buy
46,951
+125
+0.3% +$7.88K 0.37% 63
2015
Q4
$3.22M Buy
46,826
+359
+0.8% +$23.7K 0.4% 58
2015
Q3
$2.75M Buy
46,467
+322
+0.7% +$20.4K 0.36% 69
2015
Q2
$3.07M Sell
46,145
-1,572
-3% -$104K 0.37% 65
2015
Q1
$3.08M Buy
47,717
+65
+0.1% +$4.07K 0.37% 69
2014
Q4
$2.81M Sell
47,652
-100
-0.2% -$5.64K 0.35% 72
2014
Q3
$2.44M Buy
47,752
+283
+0.6% +$14.1K 0.31% 74
2014
Q2
$2.3M Sell
47,469
-1,327
-3% -$65.4K 0.29% 80
2014
Q1
$2.54M Sell
48,796
-231
-0.5% -$12.3K 0.33% 74
2013
Q4
$2.61M Sell
49,027
-487
-1% -$24.8K 0.34% 74
2013
Q3
$2.29M Sell
49,514
-305
-0.6% -$13.4K 0.32% 74
2013
Q2
$2.23M Buy
+49,819
New +$2.16M 0.32% 74

Other funds holding BMY

Bar Harbor Wealth Management's BMY Position: Q2 2026 in Review

Bar Harbor Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 34% in Q2 2026, selling an estimated $736K and leaving 25,120 shares worth $1.45M. The position accounts for 0.08% of the portfolio, ranked #134.

Bar Harbor Wealth Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.51M in Q2 2016. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Bar Harbor Wealth Management held 25,120 shares of Bristol-Myers Squibb worth $1.45M as of Q2 2026.
  • Bar Harbor Wealth Management sold 12,824 Bristol-Myers Squibb shares in Q2 2026, an estimated $736K.
  • Bristol-Myers Squibb made up 0.08% of Bar Harbor Wealth Management's portfolio in Q2 2026, its #134 holding.
  • Bar Harbor Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Bar Harbor Wealth Management's Bristol-Myers Squibb position peaked at $3.51M in Q2 2016.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Bar Harbor Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.